PTOV1 promotes cisplatin-induced chemotherapy resistance by activating the nuclear factor kappa B pathway in ovarian cancer

Chemotherapy resistance is a bottleneck for ovarian cancer treatment; therefore, revealing its regulatory mechanism is critical. In the present study, we found that prostate tumor overexpressed-1 (PTOV1) was upregulated significantly in ovarian cancer cells and tissues. Patients with high PTOV1 leve...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Hongwei, Liao, Bing, Wan, Zhiyong, Zhao, Yunhe, You, Zeshan, Liu, Jun, Lan, Jin, He, Shanyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937561/
https://www.ncbi.nlm.nih.gov/pubmed/33738336
http://dx.doi.org/10.1016/j.omto.2021.02.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937561/
https://www.ncbi.nlm.nih.gov/pubmed/33738336
http://dx.doi.org/10.1016/j.omto.2021.02.008

Ejemplares similares